Home » Study finds AI improves accuracy of stroke prediction by 70% over standard methods

To read the full story, subscribe or sign in.

Study finds AI improves accuracy of stroke prediction by 70% over standard methods

July 6, 2020

By Stacy Lawrence

Elucid Bioimaging Inc.'s Vascucap artificial intelligence-based software analyzes CT angiograms (CTA) to characterize and quantify atherosclerotic plaque to predict a patient’s stroke risk.

BioWorld MedTech Clinical Cardiovascular Diagnostics Software Artificial intelligence Digital health

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan. 17, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for January 17, 2025
Caplyta star shines as J&J takes Intra-Cellular in $14.6B deal
BioWorld
The J.P. Morgan (JPM) Healthcare Conference in San Francisco kicked off with a resounding bang as Johnson & Johnson (J&J) disclosed plans to acquire...
Proteomics study explores how protein changes influence disease
BioWorld Science
Fourteen global pharma companies are getting together to conduct the largest proteomics study to date, analyzing 600,000 blood samples held in the UK Biobank to...
Abbvie and Simcere enter a $1B T-cell engager deal
BioWorld Asia
Abbvie Inc. and Simcere Zaiming Pharmaceutical Co. Ltd. are part of the volley of large deals accompanying the opening of the 43rd annual J.P. Morgan Healthcare...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.